Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Flip-flop Pharmacokinetics – Delivering a Reversal of Disposition: Challenges and Opportunities During Drug Development
Jaime A. Yáñez, Connie M. Remsberg, Casey L. Sayre, et al.
Therapeutic Delivery (2011) Vol. 2, Iss. 5, pp. 643-672
Open Access | Times Cited: 218

Showing 1-25 of 218 citing articles:

Pharmacokinetics and Pharmacokinetic–Pharmacodynamic Correlations of Therapeutic Peptides
Lei Diao, Bernd Meibohm
Clinical Pharmacokinetics (2013) Vol. 52, Iss. 10, pp. 855-868
Closed Access | Times Cited: 279
Pharmacokinetics
Jianghong Fan, Inés A.M. de Lannoy
Biochemical Pharmacology (2013) Vol. 87, Iss. 1, pp. 93-120
Closed Access | Times Cited: 249
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Christoph U. Correll, Edward Kim, Jennifer Kern Sliwa, et al.
CNS Drugs (2021) Vol. 35, Iss. 1, pp. 39-59
Open Access | Times Cited: 121
Inhibitors of HIV-1 Attachment: The Discovery and Development of Temsavir and its Prodrug Fostemsavir
Nicholas A. Meanwell, Mark Krystal, Beata Nowicka-Sans, et al.
Journal of Medicinal Chemistry (2017) Vol. 61, Iss. 1, pp. 62-80
Closed Access | Times Cited: 116
Pharmacokinetic plasma behaviors of intravenous and oral bioavailability of thymoquinone in a rabbit model
Khalid M. Alkharfy, Ajaz Ahmad, Rao Muzaffar A. Khan, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2014) Vol. 40, Iss. 3, pp. 319-323
Closed Access | Times Cited: 107
Clinical Predictors of Venetoclax Pharmacokinetics in Chronic Lymphocytic Leukemia and Non-Hodgkin’s Lymphoma Patients: a Pooled Population Pharmacokinetic Analysis
Aksana K. Jones, Kevin J. Freise, Suresh Agarwal, et al.
The AAPS Journal (2016) Vol. 18, Iss. 5, pp. 1192-1202
Closed Access | Times Cited: 90
Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine
Daryl Hodge, David Back, Sara Gibbons, et al.
Clinical Pharmacokinetics (2021) Vol. 60, Iss. 7, pp. 835-853
Open Access | Times Cited: 88
Application of Pharmacokinetic-Pharmacodynamic Modeling in Drug Delivery: Development and Challenges
Huixi Zou, Parikshit Banerjee, Sharon Shui Yee Leung, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 80
Novel Bilayer Microarray Patch‐Assisted Long‐Acting Micro‐Depot Cabotegravir Intradermal Delivery for HIV Pre‐Exposure Prophylaxis
Ismaiel A. Tekko, Lalitkumar K. Vora, Fabiana Volpe‐Zanutto, et al.
Advanced Functional Materials (2021) Vol. 32, Iss. 9
Open Access | Times Cited: 66
Derivatization with fatty acids in peptide and protein drug discovery
Peter Kurtzhals, Søren Østergaard, Erica Nishimura, et al.
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 1, pp. 59-80
Closed Access | Times Cited: 64
Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium “Long-Acting Injectables” Working Group
Andrea Bauer, Philippe Berben, Sudhir S. Chakravarthi, et al.
Pharmaceutical Research (2023) Vol. 40, Iss. 7, pp. 1601-1631
Closed Access | Times Cited: 32
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial
Raphael J. Landovitz, Brett Hanscom, Meredith E. Clement, et al.
The Lancet HIV (2023) Vol. 10, Iss. 12, pp. e767-e778
Open Access | Times Cited: 29
Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer
Emerson A. Lim, Michael T. Schweizer, Kim N., et al.
Clinical Genitourinary Cancer (2023) Vol. 21, Iss. 3, pp. 366-375
Open Access | Times Cited: 27
Insulin Stacking Versus Therapeutic Accumulation: Understanding the Differences
Tim Heise, Luigi Meneghini
Endocrine Practice (2013) Vol. 20, Iss. 1, pp. 75-83
Closed Access | Times Cited: 77
Antileishmanial Activity of a Series of N2,N4-Disubstituted Quinazoline-2,4-diamines
Kurt S. Van Horn, Xiaohua Zhu, Trupti Pandharkar, et al.
Journal of Medicinal Chemistry (2014) Vol. 57, Iss. 12, pp. 5141-5156
Open Access | Times Cited: 68
Pharmacokinetics of Inhaled Rifampicin Porous Particles for Tuberculosis Treatment: Insight into Rifampicin Absorption from the Lungs of Guinea Pigs
L. Contreras, Jean C. Sung, Mariam Ibrahim, et al.
Molecular Pharmaceutics (2015) Vol. 12, Iss. 8, pp. 2642-2650
Closed Access | Times Cited: 64
Antibacterial and Antifungal Activity of Functionalized Cotton Fabric with Nanocomposite Based on Silver Nanoparticles and Carboxymethyl Chitosan
Carlos Alberto Arenas-Chávez, Luciana Maria de Hollanda, Arturo A. Arce‐Esquivel, et al.
Processes (2022) Vol. 10, Iss. 6, pp. 1088-1088
Open Access | Times Cited: 31
Ultra-long-acting in-situ forming implants with cabotegravir protect female macaques against rectal SHIV infection
Isabella C. Young, Ivana Massud, Mackenzie L. Cottrell, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists
Elizabeth M Sherman, Allison L. Agwu, Juan Ambrosioni, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2024) Vol. 44, Iss. 7, pp. 494-538
Open Access | Times Cited: 5
Long acting injectables for the treatment of prostate cancer
Dimple Modi, Md Sadique Hussain, Swetha Ainampudi, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 105996-105996
Closed Access | Times Cited: 5
Development and preclinical testing of a naloxone prodrug depot for extended protection against opioid overdose
Hala Aldawod, Arjun D. Patel, Rasha Emara, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Pharmacokinetics‐Based Design of Subcutaneous Controlled Release Systems for Biologics
Abigail K. Grosskopf, Antonio A. Ginart, Phillip Spinosa, et al.
CPT Pharmacometrics & Systems Pharmacology (2025)
Open Access
Ulinastatin – a newer potential therapeutic option for multiple organ dysfunction syndrome
Sarjana Atal, Shubham Atal
Journal of Basic and Clinical Physiology and Pharmacology (2015) Vol. 27, Iss. 2, pp. 91-99
Closed Access | Times Cited: 63
Tolerability and Pharmacokinetic Properties of Ciprofloxacin Dry Powder for Inhalation in Patients With Cystic Fibrosis: A Phase I, Randomized, Dose-Escalation Study
Heino Staß, Boris Weimann, Johannes Nagelschmitz, et al.
Clinical Therapeutics (2013) Vol. 35, Iss. 10, pp. 1571-1581
Open Access | Times Cited: 61
Ocular Pharmacokinetics of Therapeutic Antibodies Given by Intravitreal Injection: Estimation of Retinal Permeabilities Using a 3-Compartment Semi-Mechanistic Model
Laurence A. Hutton-Smith, Eamonn A. Gaffney, Helen M. Byrne, et al.
Molecular Pharmaceutics (2017) Vol. 14, Iss. 8, pp. 2690-2696
Open Access | Times Cited: 61
Page 1 - Next Page

Scroll to top